A Prospective, Randomized, Crossover Evaluation of the Effect of Atorvastatin on the Pharmacokinetics of Irinotecan in Colorectal Cancer Patients Receiving FOLFIRI

Trial Profile

A Prospective, Randomized, Crossover Evaluation of the Effect of Atorvastatin on the Pharmacokinetics of Irinotecan in Colorectal Cancer Patients Receiving FOLFIRI

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 26 Feb 2014

At a glance

  • Drugs Atorvastatin (Primary) ; Fluorouracil; Folinic acid; Irinotecan
  • Indications Colorectal cancer; Lipid metabolism disorders
  • Focus Pharmacokinetics
  • Most Recent Events

    • 29 May 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top